Trials / Completed
CompletedNCT02093286
Safety Profile Following Pentabio Vaccination in Indonesian Infants
Phase IV, Study of Safety Profile Following Pentabio Vaccination in Indonesian Infants
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (actual)
- Sponsor
- PT Bio Farma · Industry
- Sex
- All
- Age
- 2 Months – 11 Months
- Healthy volunteers
- Accepted
Summary
To assess any serious systemic reaction within 30 minutes after Pentabio immunization
Detailed description
Any local and systemic reaction after Pentabio immunization
Conditions
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-08-01
- Completion
- 2014-12-01
- First posted
- 2014-03-20
- Last updated
- 2017-11-06
Locations
4 sites across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT02093286. Inclusion in this directory is not an endorsement.